Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.2700 (-2.26%) ($14.2700 - $14.2700) on Wed. Aug. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.51% (three month average) | RSI | 83 | Latest Price | $14.2700(-2.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 13.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VUG(33%) XLK(33%) VT(32%) BLOK(30%) URA(30%) | Factors Impacting BCRX price | BCRX will decline at least -2.255% in a week (0% probabilities). VIXM(-16%) UUP(-14%) SMH(-9%) EDOC(-5%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.255% (StdDev 4.51%) | Hourly BBV | -2.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.54(-1.86%) | 10 Day Moving Average | $14.39(-0.83%) | 20 Day Moving Average | $12.81(11.4%) | To recent high | -3.7% | To recent low | 67.7% | Market Cap | $2.518b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |